Transrail Lighting has secured new international orders worth approximately ₹459 crore primarily in the Transmission & Distribution (T&D) business. The order wins mainly include EPC projects for construction of Transmission Lines in the Middle East and North Africa (MENA) region, further strengthening the company's international order book. With these wins, the company's order inflow for the year has reached ₹1,034 crore apart from which there is an L1 position of around ₹400 crore. As reported by Capital Market News, Randeep Narang, MD & CEO, stated that these wins further strengthen the company's position in the international T&D market and reflect customer confidence in their engineering and execution capabilities.
Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) had completed an inspection at its wholly owned subsidiary, Auroactive Pharma, located in Andhra Pradesh. According to reports from Business Standard, this development represents a significant regulatory milestone for the pharmaceutical company's subsidiary operations in the US market.
Likhitha Infrastructure announced that it has received an order worth approximately ₹510 crore ($5,40,00,000) from China Petroleum Engineering and Construction Corporation-Abu Dhabi. As reported by Business Standard, this substantial contract award demonstrates the company's strong position in international infrastructure projects. Additionally, Vikran Engineering said that it has accepted a turnkey EPC work order worth ₹3,517.98 crore from NOPL Solar Projects for the development of a 969 MW AC solar power project across multiple locations in Maharashtra.
Info Edge (India) announced that its board has approved the appointment of Himanshu Agarwal as chief financial officer (CFO) for a term of 5 years, effective from 17 September 2026. As reported by Business Standard, this leadership appointment strengthens the company's financial management structure. Additionally, Bajaj Healthcare announced that Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) has recommended for grant of approval for manufacturing and marketing of Cenobamate Tablets.
Transrail Lighting reported a consolidated net profit decline of 24.14% to ₹96.50 crore on a 3.94% drop in revenue from operations to ₹1,831.45 crore in Q4 FY26 over Q4 FY25. Despite the financial challenges, the stock rallied 3.43% to ₹528.70 after securing the new international orders. As reported by Capital Market News, the stock declined 1.20% to settle at ₹512.20 on Thursday, 25th June 2026, with the market shut today on account of Muharram. The company operates as a turnkey EPC company focused on power transmission and distribution projects, with presence in 63 countries across five continents and manufacturing facilities in India for transmission towers, conductors and monopoles.
